Status: Not yet recruiting
Clinical Study to Evaluate the LensGen® Juvene® Intraocular Lens
To assess the safety and effectiveness of the Juvene® IOL for the treatment of aphakia and mitigation of the effects of presbyopia after removal of the natural crystalline lens due to cataract.
Participants needed: 56
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: LensGen, Inc.Updated: Mar 9, 2023
Eligibility criteria
Subjects must be 22 years of age or older [+4]
Subjects with clinically significant dry eye syndrome (DES) expected to impact p... [+4]